HPV infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) meet one of the three conditions:?tested positive for HPV16/18 and pathological tissue result of LSIL or below,cervical colposcopy biopsy of LSIL or below,and LSIL lesions less than two years;?tested negative for HPV16 or 18,but positive for other types of high-risk HPV,cytological evidence of ACUS or above,cervical colposcopy biopsy of LSIL or below,and LSIL lesions less than two years;?tested negative for HPV16 or 18,but positive for other types of high-risk HPV,cytological evidence of NILM; (2) homotype HPV infection more than half a year; (3) conforming to the standard of TCM syndrome of dampness and heat; (4) women aged 25-65 with a history of sexual life and regular menstrual cycles; (5) patients with normal liver and kidney function and no history of severe drug allergy; (6) gave informed consent volunteering to participate in the study.
Exclusion criteria
Exclusion criteria: (1) women who were not avoiding pregnancy,were pregnant, or were breastfeeding; (2) those who had used other HPV drugs in the first 3 months of enrollment; (3) patients participating in clinical trials of other drugs.; (4) allergic constitution, such as allergic history of two or more drugs and food,or allergic to the ingredients of a given drug; (5) patients with HSIL or above indicated by cervical biopsy under colposcopy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cervical cytology;clearance rate of Hr-HPV;score of clinical symptom of TCM; | — |
Countries
China